Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 8 Neoplasms 8 Colorectal Neoplasms 8 Melanoma 6 Colonic Neoplasms 6 Esophageal Neoplasms 5 Stomach Neoplasms 4 Rectal Neoplasms 4 Precancerous Conditions 4 Myelodysplastic Syndromes 4 Lymphoma 4 Lung Neoplasms 4 Liver Neoplasms 4 Head and Neck Neoplasms 4 Barrett Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Salivary Gland Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Mouth Neoplasms 3 Kidney Neoplasms 3 Gastrointestinal Neoplasms 3 Gastroesophageal Reflux 3 Gastritis, Atrophic 3 Adenocarcinoma Of Esophagus 3 Uterine Cervical Neoplasms 2

Interventions

enfortumab vedotin 1 darolutamide 1 Tinzaparin 1 Technetium Tc 99m Medronate 1 Taste 1 Surveys and Questionnaires 1 Sunitinib 1 Remote Patient Monitoring 1 Radiotherapy 1 Mitomycin 1 Immunotherapy 1 Gamma Cameras 1 Drug Therapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Urogenital Neoplasms × Biopsy × Clear all

NCT03551457 2022-07-08

Avatar

University of Campinas, Brazil

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡